WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4801 Infant (under 12 months) mortality rate: 612
GDP / capita (US$): 1'2361 Child (under 5 years) mortality rate: 942

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 12'609  12'276  11'949  11'629  11'316  8'799  6'034  4'507 
Births 460  453  447  440  433  377  289  216 
Surviving infants 435  428  421  413  405  338  250  180 
Pop. less than 5 years 2'046  2'005  1'962  1'919  1'875  1'539  1'079  779 
Pop. less than 15 years 5'363  5'247  5'129  5'009  4'890  3'893  2'643  1'883 
Female 15-49 years 2'932  2'844  2'760  2'678  2'600  1'988  1'364  1'058 

Number of reported cases

(Click for retrospective incidence data for Guinea)
Diphtheria
ChartChart
  37 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  243  175  53  11  11'294  12'756  8'552 
Mumps
ChartChart
 
Pertussis
ChartChart
  247  412  2'315 
Polio*
ChartChart
  155  32 
Rubella
ChartChart
  10  55  34 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  75  51  17  245  53 
Tetanus (total)**
ChartChart
  75  51  64  245  524  482 
Yellow fever
ChartChart
  445 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea)
Vaccine year result method % card seen                                                
BCG 2011  82  DHS/MICS   44  75  82  95  84  93  71  50 
DTP1 2011  76  DHS/MICS   44  70  75  95  99*  80  67 
DTP3 2011  50  DHS/MICS   44  60  60  90  99*  85  57  20 
DTP4         
IPV1          47 
HepB_BD         
HepB3 2011  50  DHS/MICS   44  60  60  90  99*  85 
Hib3 2011  50  DHS/MICS   44  60  60  90  99*  85 
JapEnc         
MCV1          60  62  90  99*  90  59  25 
MCV2         
PCV1         
PCV3         
Pol3 2011  51  DHS/MICS   44  60  60  90  97  85  57  20 
Rota1         
RotaC         
Rubella1         
TT2plus 2011  71  DHS/MICS   44  54  62  93  86  80  43  21 
PAB         
VAD1          80  99* 
YFV 2011  38  DHS/MICS   44  60  62  90  99*  90 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea)
BCG
ChartChart
  72  82  74  82  81  50 
DTP1
ChartChart
  60  76  76  76  61  40 
DTP3
ChartChart
  51  63  63  63  46  17 
HepB3
ChartChart
  51  63  63  63 
HepB_BD
ChartChart
 
Hib3
ChartChart
  51  63  63  63 
MCV1
ChartChart
  52  62  62  62  42  35 
MCV2
ChartChart
 
PAB
ChartChart
  80  80  80  80  79  27 
PCV3
ChartChart
 
Pol3
ChartChart
  42  63  63  63  47  18 
RotaC
ChartChart
 
YFV
ChartChart
  53  63  63  63 

Number of districts in the country 38  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 16
From 50 to 79% 24
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks;
Measles 9 months; Yes
MenA Yes From May 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From November 2017
Rotavirus Yes From June 2017
TT 1st contact; +1, +6 months; +1, +1 year; Yes 15-49 years
VitaminA 6, 12 months; Yes 6-59 months
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011- 2015  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 38  38  38  38  38  38  38 

System performance

Total Nº districts in country number 38  38  38  38  38  38  38 
Nº districts with DTP3 coverage >=80% number 14  35  37  33  27  24  25 
% of districts with DTP3 coverage >=80% From 0 to 100% 37  92  97  87  71  63  66 
Nº districts with measles (MCV1) coverage >=95% number 19  23  18  21  10 
% of districts with MCV1 coverage >=95% From 0 to 100% 50  61  47  55  26  16  18 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%     49  40  60 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.